You can narrow down the results using the filters
-
Evaluation of subcutaneous injections of benzathine penicillin G for prevention of recurrent cellulitis
Expand descriptionAdmissions for recurrent cellulitis represent a significant burden to the healthcare system. One strategy for prevention includes the use of prophylactic antibiotics, commonly oral penicillin. There is increasing evidence that subcutaneous administration of high doses of benzathine penicillin G (also known as SCIP), as an alternative to intramuscular administration is effective, well tolerated and achieves favourable serum concentrations. This is an unblinded, non-randomised, opt-in, open-label phase IIa clinical trial to assess the safety, tolerability, pharmacokinetics, and preliminary efficacy of subcutaneous BPG for the prevention of cellulitis. The goal is to provide a potential alternative method of prophylaxis for recurrent cellulitis. We hypothesis that SCIP will be a safe and tolerable alternative for cellulitis prophylaxis.
-
LIGHTWELL-NT: A randomised, participant-blinded, sham-controlled trial of repeated whole body narrowband UVB (ultraviolet B) exposure on wellbeing and systemic physiology in healthy adults.
Expand descriptionNarrowband UVB is an established dermatologic phototherapy modality (6, 7). Human studies show systemic biological effects beyond the treated epidermis, including reproducible increases in serum 25-hydroxyvitamin D (4), changes in circulating immune-cell phenotypes (5), a small healthy-volunteer signal for mood improvement with an IL-6 decrease (2, 9), and a pilot healthy-human signal for gut microbiome change after repeated skin exposure (3). A 2026 observational dermatology cohort also reported improved sleep and fatigue during NB-UVB treatment (8). These findings are suggestive, not definitive: most studies are small, non-sham-controlled, conducted in patient populations, or not designed around wellbeing as a primary outcome (1, 10, 11). The central question is therefore whether repeated whole-body NB-UVB causes a measurable improvement in wellbeing beyond treatment ritual, attention, expectancy and ordinary environmental exposure. The study uses a sham cabinet condition rather than a no-treatment control, because subjective wellbeing outcomes are highly vulnerable to expectancy. The previous bright-visible-light comparator has been removed for feasibility; consequently, the sham must match visible and contextual cues as closely as practicable so that the principal contrast is presence versus absence of biologically active UVB. STUDIES REFERENCED: 1. Topp CW, The WHO-5 Well-Being Index: a systematic review. 2015. 2. Makkonen T et al. Narrow-band ultraviolet B exposures improve mood in healthy individuals differently depending on chronotype. 2019. 3. Bosman ES et al. Skin exposure to narrow band ultraviolet B light modulates the human intestinal microbiome. 2019. 4. Hart PH et al. A randomised, controlled clinical trial of narrowband UVB phototherapy for clinically isolated syndrome: the PhoCIS study. 2018. 5. Trend S et al. Short-term changes in frequencies of circulating leukocytes associated with narrowband UVB phototherapy in people with clinically isolated syndrome. 2019. 6. Kaur HS et al. Narrow-band UVB phototherapy—Australian consensus-based recommendations. Australas J Dermatol. 2022. 7. Goulden V et al. British Association of Dermatologists and British Photodermatology Group guidelines for narrowband ultraviolet B phototherapy 2022. 2022. 8. Kaya HE et al. Effects of phototherapy on sleep, fatigue and quality of life in dermatology patients: a pilot study. 2026. 9. Felis-Giemza A et al. Narrow-band ultraviolet B radiation induces the expression of beta-endorphin in human skin in vivo. 2016. 10. Cella D et al. PROMIS adult health profiles: efficient short-form measures of seven health domains. Value Health. 2019. 11. Weinfurt KP et al. Development and initial validation of the PROMIS Sexual Function and Satisfaction Measures version 2.0. J Sex Med. 2015.
-
Safety and ease of use of a heat-activated gel mixed with donor bone to rebuild jawbone during dental implant surgery, without a barrier membrane
Expand descriptionWhen a dental implant is placed, part of the implant surface is often left without bone covering it. The usual repair packs bone graft particles into the gap and covers them with a membrane, which can be fixed with tacks or screws and is technically demanding. Tegenix is a new synthetic gel that is liquid at room temperature and sets at body temperature. Mixed with donor bone particles, it is designed to hold the graft in place without a membrane, and it dissolves within about 30 days. This is the first study of Tegenix in people. It will check whether Tegenix mixed with donor bone is safe and practical to use when repairing these bone gaps during implant surgery. Ten adults having implant surgery at one specialist periodontal practice in Perth will receive the treatment (up to 15 if participants need to be replaced). The first 3 are treated one at a time, with an independent safety review before more people join. Participants are followed for about 20 months. At about 6 months, when the implant is uncovered, the new bone is measured, scanned and sampled. There is no comparison group; results will be described rather than statistically tested.
-
Integration of ultrasound to assess progress in labour: a randomised controlled trial. The primary objective of this study is to demonstrate that the use of ultrasound to monitor progress in labour will reduce the rate of intrapartum pyrexia amongst nulliparous singleton women undergoing IOL at term.
Expand descriptionAssessment of labour progress in pregnant women who are undergoing induction of labour is traditionally performed using digital vaginal examinations that can be uncomfortable and may contribute to infection risk during labour. Recent research suggests that ultrasound may be a reliable alternative to assess labour progress. This randomised clinical trial aims to determine whether using ultrasound can be used instead of digital vaginal examinations to assess the progress of labour; has an impact on discomfort and anxiety during labour assessments or has an effect on women's birth experience; reduces fever during labour and reduces infection-related complications.
-
An observational study comparing the autonomic nervous system and blood markers in people with heart symptoms but no major coronary artery blockages, people with coronary artery blockages, and healthy volunteers
Expand descriptionINFO-NOCA study aims to advance understanding of heart artery conditions that can cause heart attack–like symptoms, and even heart attacks, in the absence of cholesterol-related blockages, the most common cause of coronary events. Collectively referred to as non-obstructive coronary artery (NOCA) diseases, these conditions remain poorly understood and are often under-recognised in clinical practice. By integrating detailed clinical data, non-invasive assessments of autonomic (nerve) and vascular function, and analysis of novel blood-based biomarkers, this project seeks to uncover the biological mechanisms underlying persistent symptoms and disease progression. The study will also establish a comprehensive biobank and identify potential biomarkers to support more personalised approaches to diagnosis and management in the future. This research is conducted by a collaborative team at the South Australian Health and Medical Research Institute (SAHMRI), the Adelaide University, the Royal Adelaide Hospital (RAH), and The Queen Elizabeth Hospital (QEH), led by Principal Investigator Professor Peter Psaltis, an Interventional Cardiologist. Recruitment will occur through the RAH and QEH, with study procedures undertaken at SAHMRI and the Adelaide University Clinical Trials Laboratory at the Bonython Jubilee Building on Frome Road.
-
Effect of Intense Pulsed Light (IPL) Treatment on Vascularity and Hypertrophic Scarring in Adult Burn Donor Sites
Expand descriptionThis prospective, intra-subject controlled randomised trial will evaluate the effect of Intense Pulsed Light (IPL) therapy on vascularity and hypertrophic scarring in adult burn donor sites. Twenty adults treated through the Victorian Adult Burns Service will participate, with each participant having two comparable donor-site areas allocated to either IPL plus standard scar management or standard scar management alone. IPL treatment will commence 12 weeks after complete epithelialisation, with three treatment sessions delivered at eight-week intervals. Scar vascularity will be objectively assessed using Antera 3D imaging, with scar quality assessed using POSAS 3.0 and health-related quality of life using EQ-5D. Participants will be followed for 12 months after the final IPL treatment to assess longer-term scar outcomes.
-
Agreement between a robotic ultrasound system (VxWave) and a standard handheld ultrasound for measuring arm artery size and blood flow
Expand descriptionThis study is testing whether a new robotic ultrasound system, the VxWave Ultrasound Imaging System, measures the size of arm arteries and the speed of blood flow in them as accurately as a standard handheld ultrasound used by an expert vascular sonographer. Who is it for? Adults aged 21 years or older with complete upper limbs may be eligible. Participants may be referred from the vascular clinic at Prince of Wales Hospital, Randwick, or come from the general community. Study details Participants attend a single visit of about 2 hours at Vexev in Surry Hills, Sydney. One arm is scanned with the VxWave system, in which the arm rests on a gel-coated scan bed while an automated probe moves beneath it. The same arm is then scanned at the same three spots (two on the upper arm and one on the forearm) with a standard handheld ultrasound (Philips Lumify) by a registered vascular sonographer. Some participants have the handheld scan repeated once. Participants also complete a short comfort questionnaire. Images from both systems are measured later by a sonographer who does not know which participant or which pairing the images belong to. It is hoped this research will show that the VxWave system can produce artery measurements that agree closely with standard ultrasound, so that reliable vascular ultrasound can be performed at the point of care (for example in dialysis units) without specialist sonographer scanning.
-
Effects of a digital unsupervised Pilates program (“My Joint Pilates”) on physical function in people with knee osteoarthritis: randomised controlled trial (The PILLAR KNEE Trial)
Expand descriptionThis trial aims to find out whether a 12-week digital unsupervised Pilates program (“My Joint Pilates”), which includes Pilates exercise videos, education delivered via a website, and an exercise adherence support app (“My Exercise Messages”), improves physical function at 13 weeks compared with online education alone in people with knee osteoarthritis. After completing a baseline assessment, 206 people with knee osteoarthritis from across Australia will be randomly allocated to one of two groups: i) intervention — access to the “My Joint Pilates” website containing a self-directed 12-week Pilates program delivered by pre-recorded instructor-led videos (three sessions per week at home), information about Pilates and osteoarthritis, and the “My Exercise Messages” app; or ii) control — access to a website containing online educational information about osteoarthritis and exercise only. Outcomes will be collected using online questionnaires at baseline and 13 weeks. We hypothesise that participants in the Pilates group will have greater improvements in self-reported physical function at 13 weeks than those in the online education group.
-
Effects of a digital unsupervised Pilates program (“My Joint Pilates”) on physical function in people with hip osteoarthritis: randomised controlled trial (The PILLAR HIP Trial)
Expand descriptionThis trial aims to find out whether a 12-week digital unsupervised Pilates program (“My Joint Pilates”), which includes Pilates exercise videos, education delivered via a website, and an exercise adherence support app (“My Exercise Messages”), improves physical function at 13 weeks compared with online education alone in people with hip osteoarthritis. After completing a baseline assessment, 192 people with hip osteoarthritis from across Australia will be randomly allocated to one of two groups: i) intervention — access to the “My Joint Pilates” website containing a self-directed 12-week Pilates program delivered by pre-recorded instructor-led videos (three sessions per week at home), information about Pilates and osteoarthritis, and the “My Exercise Messages” app; or ii) control — access to a website containing online educational information about osteoarthritis and exercise only. Outcomes will be collected using online questionnaires at baseline and 13 weeks. We hypothesise that participants in the Pilates group will have greater improvements in self-reported physical function at 13 weeks than those in the online education group.
-
A fully remote, computer-based cognitive training program for older adults with subjective cognitive decline (self-noticed memory or thinking changes) or healthy cognition: a study of whether the program is feasible, acceptable and safe.
Expand descriptionAs people get older, some notice changes in their memory or thinking. This study tests a "brain training" (cognitive training) program that older adults complete on their own computer at home over 10 weeks, supported by the research team and two small-group education sessions run by video call. We are inviting community-dwelling adults aged 55 to 85 years who are either cognitively healthy or have noticed a decline in their memory or thinking but do not have a diagnosed memory disorder. Participants are placed at random into one of two groups: one group does the brain-training program plus the education sessions, and the other group does the education sessions during the study period and is offered the full program afterwards. Because this is a feasibility (pilot) study, the main aim is to find out whether the program can be delivered fully online in a way that is practical, acceptable to participants, and safe - for example, how many people take part, how many complete the sessions, and whether they find it helpful and easy to use. We will also take early measurements of thinking skills and wellbeing to help design a larger future study. The findings will show whether a fully remote brain-training program is worth testing in a bigger trial to support healthy brain ageing.